Scientists develop new drug screening tool for dystonia

Researchers have identified a common mechanism underlying separate forms of dystonia, a family of brain disorders that cause involuntary, debilitating and often painful movements, including twists and turns of different parts of the body. The research has led to the development of a new cell-based test that is being deployed on a large scale to identify new drug candidates to treat dystonia.